Analyze healthcare legislative and regulatory environment to assess impact on clients and develop strategies to drive policy solutions

Supervised and directed team of 4 in developing strategies for priority issues including drug pricing, Medicare, Medicaid, HIV, Respiratory, Vaccines, and Lupus. Served as Policy Lead on Price/Value Team; advised on drug pricing issues including rebates and transparency.I advanced proactive strategies to shape the external environment • I analyzed and interpreted impact of legislation and regulations on business. • Developed positions, legislative language and talking points for state and federal lobbyists. • Created State Operations Matrix Team of relevant internal stakeholders to evaluate threats posed by state proposals, escalated to senior management, and developed mitigating strategies to address. • Developed and drove internal adoption of process for prioritizing GSK Policy issues. • Increased success of priorities and improved allocation of work across teams. • Spearheaded response to President Trump Blueprint on Drug Pricing. • Created workstreams to coordinate GSK/ViiV response with input from all relevant stakeholders. • Led efforts to preserve market-based healthcare system that fosters innovation• Preserved patient access to medicines by ensuring that patients have access to needed medicines.• Mitigated enactment of negative federal bills; defeated onerous drug pricing bills

Led team of 5 in analyzing and assessing impact of federal and state legislative proposals and identified proactive proposals that demonstrated value of medicines. Formulated strategies to defeat or enact legislation; guided preparation of amendments, talking points, and communications. • Built high-performing team that prioritized and focused on translating business priorities into policy opportunities for pull-through at federal and state levels.• Championed PDUFA V legislation including provisions that appropriately treated prescription drugs imported for Research and Development purposes.• Reduced regulatory burdens that threatened to duplicate existing importation process. • Elected to Chair Women in Government's Business Council; educated state legislators on GSK priority issues, including adult vaccines, lupus, COPD, oncology, medication management, and delivery and payment reforms. • Achieved 12 years of exclusivity for reference biologics, which enabled manufacturers time to recoup research and development investment by championing enactment of biosimilars pathway in ACA. • Selected as Board Member for GSK's Political Action Committee in 2011.• Led Comprehensive Medication Management strategy that produced state laws to improve patients' health for those in coordinated care settings and ensured patients had access to appropriate therapies. • Assisted Government Relations in enacting 15+ state laws to require oncology parity so that a patient's copayment did not vary depending on whether a medicine was prescribed as an oral or intravenous formulation.• Drove effort that led to enactment of 40+ state bills that raised awareness about lupus, HIV, respiratory disease, and vaccine preventable diseases and improved access to needed medication.

 Leadership: Manage and develop staff of attorneys and a pharmacist to build the best policy team in the industry. Strategy Development: Lead strategic planning process for priority issues for direct reports as well as Government Relations and Advocacy teams.  Policy Expertise: Analyze and develop key public policies regarding the political environment affecting the pharmaceutical industry; analyze federal and state legislation and formulate strategy to defeat or enact legislation; prepare amendments, talking points and communication materials for Government Relations on key issues, including healthcare reform, Medicaid, Medicare, drug pricing, biosimilars, importation, privacy, and civil justice reform; advise senior executives on strategies to address legislative proposals affecting prescription drug industry; shape external government environment for HIV, lupus, respiratory and oncology

 Prepared internal and external communications on medical data privacy, state Medicaid programs, tort reform and genetics in support of State Government Affairs Analyzed and prepared legislative amendment strategy for State Government Affairs on issues affecting GSK

 Provided legal counsel and analyzed federal legislation affecting physicians including medical malpractice reform, Medicaid and Medicare reimbursement, medical data privacy, and HIV Served as Legislative Counsel to AMA’s Council on Legislation, a principal advisory unit to AMA Board of Trustees Prepared legislative amendments and talking points and met with Members of Congress and their staffs on issues affecting physicians